Marcel Frenkel

Co-Founder & CEO at Ten63 Therapeutics

Marcel Frenkel PhD is a biochemist with a background in computational protein and drug design, immunology and cancer cell biology. After losing his mother to pancreatic cancer, Marcel’s desire and vision on how to change the prognosis of patients suffering from cancer and other deadly diseases has brought a team of amazing scientists, engineers, and biotech experts together and become Ten63’s mission.

Location

Raleigh, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Ten63 Therapeutics

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.


Employees

1-10

Links